K vs VKTX · P/E 23, $29.03B cap vs $3.97B cap
Kellanova (K) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
K does not have a complete income-statement cache yet.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
K currently screens at market cap $29.03B and trailing P/E 22.8. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the K and VKTX stock pages for the full models.
Not investment advice.